Pre-therapy | Group A (SnF group) | Group B (SA group) | Test value | p-value | Sig. | |
Arabic-VHI | ||||||
Total score | Mean ± SD | 77.10 ± 10.30 | 74.77 ± 10.18 | 0.882 | 0.381 | NS |
Range | 59–92 | 57–90 | ||||
Functional domain | Mean ± SD | 30.00 ± 5.72 | 26.03 ± 5.32 | 2.780 | 0.007 | HS |
Range | 20–39 | 18–34 | ||||
Physical domain | Mean ± SD | 27.67 ± 5.29 | 22.63 ± 5.35 | 3.664 | 0.001 | HS |
Range | 18–36 | 15–30 | ||||
Emotional domain | Median (IQR) | 19.5 (16–23) | 22 (19–26) | − 2.642 | 0.008 | HS |
Range | 13–26 | 18–29 | ||||
Post-therapy | Group A (SnF group) | Group B (SA group) | Test value | p-value | Sig. | |
Arabic-VHI | ||||||
Total score | Mean ± SD | 17.30 ± 5.76 | 15.20 ± 5.09 | 1.496 | 0.140 | NS |
Range | 8–25 | 6–22 | ||||
Functional domain | Mean ± SD | 8.87 ± 2.86 | 8.33 ± 2.09 | 0.824 | 0.413 | NS |
Range | 4–13 | 5–11 | ||||
Physical domain | Mean ± SD | 3.27 ± 1.60 | 4.33 ± 2.41 | − 2.020 | 0.048 | S |
Range | 1–6 | 1–8 | ||||
Emotional domain | Median (IQR) | 6 (4–9) | 2 (1–2) | − 5.788 | 0.000 | HS |
Range | 2–10 | 0–3 |